MARISSA LAMARY-BALTZER: Open Payments
NPI 1720689011 · CORAOPOLIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $121 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 4 | $170 |
| Ipsen Biopharmaceuticals, Inc | 1 | $145 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Celgene Corporation | 1 | $18 |
| Eisai Inc. | 1 | $15 |
Products named: CABOMETYX, Onivyde, SCEMBLIX, Odomzo, KISQALI, REBLOZYL, Lenvima.
Industry payments across PA — which companies pay providers there.
